(By Balachander) Bruker Corp. (NASDAQ:BRKR), which makes life science systems, forecasts earnings for the second quarter that trailed market expectations, citing softening customer demand, higher spending and a weaker euro.
The Billerica, Massachusetts-based company expects adjusted earnings per share in the range of $0.11 to $0.13, down from $0.20 in the same period of last year. Revenue is projected to increase to about $420 million from $401 million reported a year-ago.
Wall Street analysts, on average, expect earnings of $0.21 per share on revenue of $434.50 million.
In the first quarter, Bruker earned 14 cents a share on an adjusted basis, on revenue of $406 million.
The company's technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies and X-ray technologies, among others.
The stock, which has been trading between $11.48 and $20.61 over the past year, closed Monday's regular trading at $13.36.